Expert Working Groups


Coronavirus

Members

  • Hana El Sahly, Baylor
  • Paul Spearman, Cincinnati Children's
  • Tim Uyeki, CDC
  • Lisa Jackson, Kaiser
  • Sharon Frey, St. Louis University
  • Mark Denison, Vanderbilt
  • Helen Chu, University of Washington
  • Meagan Deming, University of Maryland
  • Ann Falsey, University of Rochester
  • Nadine Rouphael, Emory University
  • Mark Mulligan, New York University
  • John Beigel, NIH
  • Chris Roberts, NIH
  • Robert Atmar, Baylor
  • Michael Gale, University of Washington
  • David Stephens, Emory University
  • Kathy Neuzil, University of Maryland
  • Anne Rinaldi, FHI360
  • Lauren Hale, FHI360
  • Monica Farley, Emory University

Emerging Infectious Diseases

Pathogens/Diseases: Coccidioidomycosis, Candida (including C. auris), Ebola, mosquito tick and other borne diseases including dengue, Zika and Lyme Disease; other emerging viruses- Rift valley fever, Lassa, biodefense pathogens (anthrax, botulism, etc), antibiotic resistant bacterial infections such as Enterobacteriaceae, Staphylococcus aureus, Acinetobacter, Pseudomonas

Members

  • Buddy Creech, Vanderbilt
  • Ann Falsey, University of Rochester
  • Mark Challberg, NIH
  • Kay Tomashek, NIH
  • Jean Patterson, NIH
  • Greg Deye, NIH
  • Mallo Rao, NIH
  • Rima Kabbaz, CDC
  • Wilbur Chen, University of Maryland
  • Monica McArthur, University of Maryland
  • Jesse Waggoner, Emory University
  • Matt Collins, Emory University
  • Getahun Abate, St. Louis University
  • Angela Branche, University of Rochester
  • Pedro Piedra, Baylor
  • Vanessa Raabe, New York University
  • Bo Shopsin, New York University
  • Grant Paulsen, Cincinnati Children's
  • Rhea Coler, Kaiser
  • Walt Orenstein, Emory University
  • Igho Ofotokun, Emory University
  • Michael Gale, University of Washington
  • Ginger Pittman, FHI360
  • Lauren Hale, FHI360
  • Robert Atmar, Baylor
  • Monica Farley, Emory University

Malaria/Tropical Diseases

Pathogens/Diseases: Malaria, Schistosomiasis, Filariasis, soil-transmitted helminths, Leishmaniasis, novel vector control and interventions; Special considerations given to CHIM and International Sites

Members

  • Dan Hoft, St. Louis University
  • Nadine Rouphael, Emory University
  • Greg Deye, NIH
  • Mallo Rao, NIH
  • Jill Weatherhead, Baylor
  • Matthew Laurens, University of Maryland
  • Kirsten Lyke, University of Maryland
  • Sarah George, St. Louis University
  • Sean Murphy, Kaiser
  • Jim Kublin, University of Washington
  • Claudio Lanata, Vanderbilt
  • David Stephens, Emory University
  • Kathy Edwards, Vanderbilt
  • Julie McElrath, Fred Hutch
  • Noelle Myler, FHI360
  • Shilysha Davis-Dublin, FHI360
  • Paul Spearman, Cincinnati Children's
  • Jeanne Marrazzo, University of Alabama at Birmingham

Respiratory Infections

Pathogens/Diseases: Influenza, RSV, emerging respiratory viruses including coronaviruses, novel TB vaccines, pertussis, Group A Streptococcus, Streptococcus pneumoniae, Group B Streptococcus, Neisseria meningitidis, nontypable H. Influenzae

Members

  • Hana El Sahly, Baylor
  • Lisa Jackson, Kaiser
  • Chris Roberts, NIH
  • Kristina Lu, NIH
  • Dikoe Makhene, NIH
  • Sam Posner, NCIRD
  • Wendy Keitel, Baylor
  • David Topham, Rochester
  • Evan Anderson, Emory University
  • Sharon Frey, St. Louis University
  • Helen Chu, University of Washington
  • John Williams, Vanderbilt
  • David Bernstein, Cincinnati Children's
  • Felicia Scaggs Huang, Cincinnati Children's
  • Christina Rostad, Emory University
  • Justin Ortiz, University of Maryland
  • Adam Ratner, New York University
  • Kathy Neuzil, University of Maryland
  • Monica Farley, Emory University
  • Julie McElrath, Fred Hutch
  • Ginger Pittman, FHI360
  • Shilysha Davis-Dublin, FHI360
  • Robert Atmar, Baylor

Enteric Infections

Pathogens/Diseases: Shigella, Campylobacter, non-typhoidal Salmonella, C. difficile, Cryptosporidium, hepatitis and rotavirus, enteroviruses, norovirus

Members

  • Karen Kotloff, University of Maryland
  • Robert Frenck, Cincinnati Children's
  • Melody Mills, NIH
  • Carolyn Deal, NIH
  • Lori Newman, NIH
  • Patti Griffin, CDC
  • Judd Walson, University of Washington
  • Maribeth Nicholson, Vanderbilt
  • Sasirekha Ramani, Baylor
  • James Kublin, Kaiser
  • Sharon Frey, St. Louis University
  • Mary Caserta, University of Rochester
  • Craig Hendrix, Johns Hopkins
  • Jeff Lennox, Emory University
  • Michael Gale, University of Washington
  • Anne Rinaldi, FHI360
  • Shilysha Davis-Dublin, FHI360
  • Jeanne Marrazzo, University of Alabama at Birmingham
  • Paul Spearman, Cincinnati Children's

Sexually Transmitted Infections

Pathogens/Diseases: N. gonorrhoeae, Chlamydia trachomatis, Syphilis (Treponema pallidum), herpes simplex virus, Trichomonas vaginalis, Mycoplasma genitalium, HPV

Members

  • Anna Wald, University of Washington
  • Jeanne Marrazzo, University of Alabama at Birmingham
  • Tom Hiltke, NIH
  • Carolyn Deal, NIH
  • Lori Newman, NIH
  • Gail Bolan, CDC
  • Carlos Del Rio, Emory University
  • Jim Campbell, University of Maryland
  • Scott McClelland, University of Washington
  • Michael Keefer, University of Rochester
  • Jose Serpa-Alvarez, Baylor
  • Lisa Jackson, Kaiser
  • Hilary Reno, Vanderbilt
  • Daniela Dimarco, University of Rochester
  • John Kriesel, St. Louis University-Utah
  • Kimberly Workowski, Emory University
  • Jonathan Zenilman, Johns Hopkins
  • Christine Posavad, Fred Hutch
  • Lauren Hale, FHI360
  • Paul Spearman, Cincinnati Children's

Organizational Structure